Clinical Researcher, bioMérieux, Inc., Quidel and Medscape
BIOGRAPHY
MAY 08, 2017 10:00 AM EDT
WEBINAR: CDC Evaluation of a 2-Tier Lyme Disease EIA Testing Method and Potential Diagnostic Significance
Speaker
Event Date & Time
DATE: May 8th, 2017
TIME: 10:00AM PT, 11:00AM MT, 12:00PM CT, 1:00PM ET
Abstract
This webinar will describe the potential diagnostic benefits of using the dissociated VIDAS Lyme IgM II and VIDAS Lyme IgG II assays in a 2-tier EIA approach versus the use of the standard EIA / western blot algorithm.
You May Also Like
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
MAY 08, 2017 10:00 AM EDT
Share
WEBINAR: CDC Evaluation of a 2-Tier Lyme Disease EIA Testing Method and Potential Diagnostic Significance
Loading Comments...